← Leaderboards
Patrick S. Moore
Princeton University
$14,092,707
Attributed
$14,092,707
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,092,707 · 8
By mechanism
R01$6,972,676 · 4
R35$6,212,231 · 1
R33$756,763 · 1
P30$151,037 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorVirusProteinsViralMerkel Cell CarcinomaHuman Herpesvirus 8ImmuneCell LineInfectionFundingCellsMolecularTumorigenesisDigitalPolyomavirusViral ProteinsSkin CancerAcquired Immunodeficiency SyndromeGenerationsBasePathway InteractionsCancer CellCancer Etiology
Grant awards (43)
Discovery and Characterization of New Human Cancer Viruses$931,369
R35 · FY2022 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$931,373
R35 · FY2021 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$677,355
R35 · FY2020 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$903,431
R35 · FY2019 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$929,418
R35 · FY2018 · CA · contact PI
Cancer Virology Program (Project-002)$34,500
P30 · FY2018 · CA · contact PI
Cancer Virology Program (Project-002)$8,614
P30 · FY2018 · CA · contact PI
Cancer Virology Program (Project-002)$3,972
P30 · FY2018 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$922,575
R35 · FY2017 · CA · contact PI
Cancer Virology Program (Project-002)$34,500
P30 · FY2017 · CA · contact PI
Discovery and Characterization of New Human Cancer Viruses$916,710
R35 · FY2016 · CA · contact PI
Cancer Virology Program (Project-002)$34,672
P30 · FY2016 · CA · contact PI
Role of a New Polyomavirus in Merkel Cell Carcinoma$442,893
R01 · FY2015 · CA · contact PI
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom$340,117
R01 · FY2015 · CA · contact PI
Cancer Virology Program (Project-002)$34,779
P30 · FY2015 · CA · contact PI
Role of a New Polyomavirus in Merkel Cell Carcinoma$441,814
R01 · FY2014 · CA · contact PI
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom$329,655
R01 · FY2014 · CA · contact PI
Role of a new polyomavirus in Merkel cell carcinoma$397,394
R01 · FY2013 · CA · contact PI
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom$316,705
R01 · FY2013 · CA · contact PI
Role of a new polyomavirus in Merkel cell carcinoma$422,760
R01 · FY2012 · CA · contact PI
MCC Tumor-Specific Biomarkers: Basis for Rational Therapy of Merkel Cell Carcinom$336,920
R01 · FY2012 · CA · contact PI
Role of a new polyomavirus in Merkel cell carcinoma$437,168
R01 · FY2011 · CA · contact PI
Role of a new polyomavirus in Merkel cell carcinoma$450,686
R01 · FY2010 · CA · contact PI
Protein Biomarkers for a New Human Polyomavirus in AIDS-related Malignancies$340,875
R01 · FY2010 · CA · contact PI
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein$255,442
R01 · FY2010 · CA · contact PI
Role of a new polyomavirus in Merkel cell carcinoma$455,105
R01 · FY2009 · CA · contact PI
Protein Biomarkers for a New Human Polyomavirus in AIDS-related Malignancies$340,875
R01 · FY2009 · CA · contact PI
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein$255,442
R01 · FY2009 · CA · contact PI
Emerging Technologies Applied to the Discovery of Human Tumor Viruses$155,925
R33 · FY2009 · CA · contact PI
Emerging Technologies Applied to the Discovery of Human Tumor Viruses$98,513
R33 · FY2009 · CA · contact PI
Protein Biomarkers for a New Human Polyomavirus in AIDS-related Malignancies$340,875
R01 · FY2008 · CA · contact PI
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein$255,442
R01 · FY2008 · CA · contact PI
Emerging Technologies Applied to the Discovery of Human Tumor Viruses$181,913
R33 · FY2008 · CA · contact PI
Emerging Technologies Applied to the Discovery of Human Tumor Viruses$112,512
R33 · FY2008 · CA · contact PI
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein$255,442
R01 · FY2007 · CA · contact PI
Emerging Technologies Applied to the Discovery of Human Tumor Viruses$207,900
R33 · FY2007 · CA · contact PI
Enhanced Cell-mediated Immunogenicity of KSHV LANA1 Protein$263,071
R01 · FY2006 · CA · contact PI
VIRUS AND CELL GENE EXPRESSION IN KAPOSI SARCOMA ASSOCIATED HERPESVIRUS TUMORS$0
P01 · FY2002 · CA
VIRUS AND CELL GENE EXPRESSION IN KAPOSI SARCOMA ASSOCIATED HERPESVIRUS TUMORS$0
P01 · FY2002 · CA
VIRUS AND CELL GENE EXPRESSION IN KAPOSI SARCOMA ASSOCIATED HERPESVIRUS TUMORS$0
P01 · FY2001 · CA
VIRUS AND CELL GENE EXPRESSION IN KAPOSI SARCOMA ASSOCIATED HERPESVIRUS TUMORS$0
P01 · FY2001 · CA
KSHV-ENCODED CYTOKINE PATHWAY PROTEINS IN AIDS NEOPLASIA$293,995
R01 · FY2000 · CA
VIRUS AND CELL GENE EXPRESSION IN KAPOSI SARCOMA ASSOCIATED HERPESVIRUS TUMORS$0
P01 · FY2000 · CA